• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1%盐酸阿可乐定对非选择性β受体阻滞剂的相加作用。

Additive effect of 1% apraclonidine hydrochloride to nonselective beta-blockers.

作者信息

Yaldo M K, Shin D H, Parrow K A, Lee S H, Lee S Y

机构信息

Kresge Eye Institute, Wayne State University, Detroit, MI 48201.

出版信息

Ophthalmology. 1991 Jul;98(7):1075-8. doi: 10.1016/s0161-6420(91)32189-4.

DOI:10.1016/s0161-6420(91)32189-4
PMID:1679916
Abstract

The short-term additive effect and side effects of adding 1% apraclonidine hydrochloride to nonselective beta-blockers were investigated in 21 patients with ocular hypertension or early primary open-angle glaucoma. After a unilateral single dose application of topical 1% apraclonidine hydrochloride, intraocular pressure (IOP), heart rate, and interpalpebral distance were measured. The mean IOP of treated eyes showed a decline from a baseline of 20.0 +/- 3.0 mmHg to 18.1 +/- 3.2 mmHg at 1 hour (P less than 0.005), 16.5 +/- 2.6 mmHg at 2 hours (P less than 0.001), 15.2 +/- 2.5 mmHg at 3 hours (P less than 0.001), 18.5 +/- 3.0 mmHg at 12 hours (P = 0.02), and 19.2 +/- 2.9 mmHg at 24 hours (P = 0.2). No statistically significant change in the heart rate was seen. The interpalpebral distance of the treated eyes showed a significant increase (P less than 0.05) at all time intervals except 24 hours (P = 0.17). The authors conclude that 1% apraclonidine hydrochloride provides an additive pressure-lowering effect to nonselective beta-blockers for at least 12 hours after a single application, and shows promise as a useful adjunctive agent for short-term use in glaucoma therapy.

摘要

在21例高眼压症或早期原发性开角型青光眼患者中,研究了在非选择性β受体阻滞剂基础上加用1%盐酸阿可乐定的短期附加效应和副作用。在单侧单次局部应用1%盐酸阿可乐定后,测量眼压(IOP)、心率和睑裂间距。治疗眼的平均眼压在1小时时从基线的20.0±3.0 mmHg降至18.1±3.2 mmHg(P<0.005),2小时时为16.5±2.6 mmHg(P<0.001),3小时时为15.2±2.5 mmHg(P<0.001),12小时时为18.5±3.0 mmHg(P = 0.02),24小时时为19.2±2.9 mmHg(P = 0.2)。心率未见统计学显著变化。治疗眼的睑裂间距在除24小时外的所有时间间隔均有显著增加(P<0.05),24小时时(P = 0.17)。作者得出结论,单次应用1%盐酸阿可乐定后,至少在12小时内可为非选择性β受体阻滞剂提供附加的降眼压作用,有望作为青光眼治疗短期使用的有用辅助药物。

相似文献

1
Additive effect of 1% apraclonidine hydrochloride to nonselective beta-blockers.1%盐酸阿可乐定对非选择性β受体阻滞剂的相加作用。
Ophthalmology. 1991 Jul;98(7):1075-8. doi: 10.1016/s0161-6420(91)32189-4.
2
The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.阿可乐定作为噻吗洛尔治疗辅助药物的疗效。阿可乐定辅助治疗研究组。
Arch Ophthalmol. 1995 Mar;113(3):287-92. doi: 10.1001/archopht.1995.01100030041019.
3
A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.一项关于0.25%和0.5%阿可乐定与0.5%噻吗洛尔疗效及副作用的90天研究。阿可乐定初始治疗研究组。
Arch Ophthalmol. 1996 Aug;114(8):938-42. doi: 10.1001/archopht.1996.01100140146006.
4
The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients.阿可乐定与马来酸噻吗洛尔在剥脱性青光眼与原发性开角型青光眼患者中的比较性降眼压效果。
Eye (Lond). 1999 Jun;13 ( Pt 3a):314-8. doi: 10.1038/eye.1999.81.
5
Comparison of apraclonidine and timolol in chronic open-angle glaucoma. A three-month study.阿可乐定与噻吗洛尔治疗慢性开角型青光眼的比较。一项为期三个月的研究。
Ophthalmology. 1993 Sep;100(9):1318-23. doi: 10.1016/s0161-6420(13)31818-1.
6
A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure.单侧使用溴莫尼定和阿可乐定对眼压升高患者的短期降压效果及副作用比较。
Ophthalmologica. 2002 Jan-Feb;216(1):45-9. doi: 10.1159/000048296.
7
The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.0.25%阿可乐定预防钕:钇铝石榴石激光后囊切开术后眼压升高的效果
Eur J Ophthalmol. 1998 Jul-Sep;8(3):167-72. doi: 10.1177/112067219800800309.
8
Effect of apraclonidine in long-term timolol users.阿可乐定对长期使用噻吗洛尔患者的影响。
Ophthalmology. 1991 Oct;98(10):1543-6. doi: 10.1016/s0161-6420(91)32106-7.
9
Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group.盐酸阿可乐定联合最大耐受药物治疗青光眼的短期疗效。阿可乐定最大耐受药物治疗研究组。
Am J Ophthalmol. 1995 Oct;120(4):423-32. doi: 10.1016/s0002-9394(14)72655-8.
10
Apraclonidine and clonidine: a comparison of efficacy and side effects in normal and ocular hypertensive volunteers.阿可乐定与可乐定:正常及高眼压志愿者的疗效与副作用比较
Int Ophthalmol. 1992 Sep;16(4-5):337-42. doi: 10.1007/BF00917987.

引用本文的文献

1
Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.局部应用盐酸阿可乐定治疗控制不佳的青光眼。阿可乐定最大耐受药物治疗研究组。
Trans Am Ophthalmol Soc. 1995;93:421-38; discussion 439-41.
2
Efficacy of apraclonidine ophthalmic solution (Iopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma.阿可乐定滴眼液(Iopidine)对疑似硅油诱导性青光眼和原发性开角型青光眼的疗效。
Graefes Arch Clin Exp Ophthalmol. 1995 Jan;233(1):13-20. doi: 10.1007/BF00177780.